Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF - PubMed (original) (raw)
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
E J Filardo et al. Mol Endocrinol. 2000 Oct.
Abstract
Estrogen rapidly activates the mitogen-activated protein kinases, Erk-1 and Erk-2, via an as yet unknown mechanism. Here, evidence is provided that estrogen-induced Erk-1/-2 activation occurs independently of known estrogen receptors, but requires the expression of the G protein-coupled receptor homolog, GPR30. We show that 17beta-estradiol activates Erk-1/-2 not only in MCF-7 cells, which express both estrogen receptor alpha (ER alpha) and ER beta, but also in SKBR3 breast cancer cells, which fail to express either receptor. Immunoblot analysis using GPR30 peptide antibodies showed that this estrogen response was associated with the presence of GPR30 protein in these cells. MDA-MB-231 breast cancer cells (ER alpha-, ER beta+) are GPR30 deficient and insensitive to Erk-1/-2 activation by 17beta-estradiol. Transfection of MDA-MB-231 cells with a GPR30 complementary DNA resulted in overexpression of GPR30 protein and conversion to an estrogen-responsive phenotype. In addition, GPR30-dependent Erk-1/-2 activation was triggered by ER antagonists, including ICI 182,780, yet not by 17alpha-estradiol or progesterone. Consistent with acting through a G protein-coupled receptor, estradiol signaling to Erk-1/-2 occurred via a Gbetagamma-dependent, pertussis toxin-sensitive pathway that required Src-related tyrosine kinase activity and tyrosine phosphorylation of tyrosine 317 of the Shc adapter protein. Reinforcing this idea, estradiol signaling to Erk-1/-2 was dependent upon trans-activation of the epidermal growth factor (EGF) receptor via release of heparan-bound EGF (HB-EGF). Estradiol signaling to Erk-1/-2 could be blocked by: 1) inhibiting EGF-receptor tyrosine kinase activity, 2) neutralizing HB-EGF with antibodies, or 3) down-modulating HB-EGF from the cell surface with the diphtheria toxin mutant, CRM-197. Our data imply that ER-negative breast tumors that continue to express GPR30 may use estrogen to drive growth factor-dependent cellular responses.
Similar articles
- The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Maggiolini M, Vivacqua A, Fasanella G, Recchia AG, Sisci D, Pezzi V, Montanaro D, Musti AM, Picard D, Andò S. Maggiolini M, et al. J Biol Chem. 2004 Jun 25;279(26):27008-16. doi: 10.1074/jbc.M403588200. Epub 2004 Apr 16. J Biol Chem. 2004. PMID: 15090535 - Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
Santen R, Jeng MH, Wang JP, Song R, Masamura S, McPherson R, Santner S, Yue W, Shim WS. Santen R, et al. J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):115-25. doi: 10.1016/s0960-0760(01)00151-0. J Steroid Biochem Mol Biol. 2001. PMID: 11850215 Review.
Cited by
- The G-Protein-Coupled Estrogen Receptor Agonist G-1 Mediates Antitumor Effects by Activating Apoptosis Pathways and Regulating Migration and Invasion in Cervical Cancer Cells.
Gaxiola-Rubio A, Jave-Suárez LF, Hernández-Silva CD, Ramírez-de-Arellano A, Villegas-Pineda JC, Lizárraga-Ledesma MJ, Ramos-Solano M, Diaz-Palomera CD, Pereira-Suárez AL. Gaxiola-Rubio A, et al. Cancers (Basel). 2024 Sep 27;16(19):3292. doi: 10.3390/cancers16193292. Cancers (Basel). 2024. PMID: 39409923 Free PMC article. - Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment.
Capatina AL, Malcolm JR, Stenning J, Moore RL, Bridge KS, Brackenbury WJ, Holding AN. Capatina AL, et al. Front Cell Dev Biol. 2024 Aug 30;12:1421629. doi: 10.3389/fcell.2024.1421629. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39282472 Free PMC article. Review. - The Pros and Cons of Estrogens in Prostate Cancer: An Update with a Focus on Phytoestrogens.
Figueira MI, Carvalho TMA, Macário-Monteiro J, Cardoso HJ, Correia S, Vaz CV, Duarte AP, Socorro S. Figueira MI, et al. Biomedicines. 2024 Jul 23;12(8):1636. doi: 10.3390/biomedicines12081636. Biomedicines. 2024. PMID: 39200101 Free PMC article. Review. - Secoisolariciresinol diglucoside attenuates neuroinflammation and cognitive impairment in female Alzheimer's disease mice via modulating gut microbiota metabolism and GPER/CREB/BDNF pathway.
Jia M, Ning F, Wen J, Wang X, Chen J, Hu J, Chen X, Liu Z. Jia M, et al. J Neuroinflammation. 2024 Aug 12;21(1):201. doi: 10.1186/s12974-024-03195-4. J Neuroinflammation. 2024. PMID: 39135052 Free PMC article. - The Role of Estrogen and Estrogen Receptors in Head and Neck Tumors.
Kranjčević JK, Čonkaš J, Ozretić P. Kranjčević JK, et al. Cancers (Basel). 2024 Apr 19;16(8):1575. doi: 10.3390/cancers16081575. Cancers (Basel). 2024. PMID: 38672656 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous